AbbVie ending R&D deal with Alphabet-backed Calico (ABBV:NYSE)

AbbVie (ABBV) is terminating a decade-long R&D collaboration with Calico Life Sciences, a company founded by Alphabet (GOOG) (GOOGL) to focus on age-related conditions, according to a report from Stat News on Wednesday. Citing internal emails sent on Tuesday, the publication ...